webinar register page

Webinar banner
Remembering Dr José Baselga
Dr. José Baselga, a world-renowned oncologist, was involved in the development of 12 approved cancer drugs*, including Herceptin for breast cancer. His contributions helped transform cancer care and saved countless lives.

This Saturday, friends, colleagues, and patients will join José's family to pay tribute to his achievements, humanity, and celebrate his legacy. Please join us via Zoom at 3pm EST, Saturday March 27. Among those who will share memories of José include:

1) Anas Younes (AstraZeneca)
2) Jonathan Kurie (MD Anderson)
3) Eulalia Baselga (SJD Barcelona Children's Hospital, and José’s sister)
4) Clifford Hudis (ASCO)
5) Maurizio Scaltriti (AstraZeneca)
6) Jean Charles Soria (Institut Gustave Roussy)
7) Leonidas Platanias (Lurie Cancer Center)
8) David Hyman (Loxo Oncology, Eli Lilly)
9) Ross Levine (Memorial Sloan Kettering)
10) Josep Tabernero (Vall d’Hebron Institute of Oncology)
11) Rick Klausner (Lyell Immunopharma, GRAIL, Juno)
12) Antoni Ribas (AACR)
13) Jorie Graham (Pulitzer winning poet & former patient)

Please use this link below to register for the event, and to indicate whether you would like to share your memories of Dr. Baselga (if time permits)


*Dr. Baselga contributed to the development of Erbitux, Herceptin, Perjeta, Afinitor, Kadcyla, Tykerb, Iressa, Tarceva, Nerlynx, Lynparza, Piqray, and Enhertu.

Disclaimer: This event is organized by José’s friends, and is not an AstraZeneca-sponsored event. We are grateful to AstraZeneca for providing technical support for registration and event hosting. If you have any questions, please contact Jing Liang at jing.liang@umbrex.com

Mar 27, 2021 03:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: jing.liang@umbrex.com.